Additionally, although our research shows that COL22A1 expression correlates with common immune checkpoints and MHC loci, suggesting its potential as a target for immune evasion, it remains unclear whether this effect is mediated through immune checkpoints or influences the interactions between immune and tumor cells via the extracellular matrix. The gene discussed is HLA-C; the disease is neoplasm.